- Research works
- 27 ▼ 46% vs 2013–17
- Citations
- 1.1k 39.0 per fractional work
- Top-10% rate
- 21.1% record average 16.5%
- Open access
- 66% world 28%
Not ranked overall: PaxVax (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at PaxVax (United States)?
Ranked on the composite score, Marc Gurwith lead among researchers whose main affiliation is PaxVax (United States).
- 1 Marc Gurwith United States · #451,061 worldwide 97 citations · 16 works
Which keywords describe research at PaxVax (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Immune Response, Vaccine Development, Genetic Diversity, Vaccine, Zoonotic Infections and Public Health.
- H1N1
- Regulation
- Cholera
- Viral Hemorrhagic Fevers
- Bacterial Pathogenesis
- Vaccines
- Vector Control
- Genomic Analysis
- Diagnosis
- Pandemic
- Zoonotic Infections
- Vaccine
- Vaccine Development
- Pathogenesis
- Epidemiology
- Immune Response
- Genetic Diversity
- Public Health
- Immunotherapy
- Zoonotic Transmission
- Gene Therapy
- Host-Pathogen Interactions
- Innate Immunity
- Antibodies
- Bunyavirus
- Virus
- Genomics
- Vibrio cholerae
- Influenza
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Epidemiology8▲ 7.5×22 topics
- Pathogenesis4▲ 24×9 topics
- Immune Response4▲ 21×11 topics
- Vaccine Development2▲ 29×5 topics
- Genetic Diversity2▲ 16×3 topics
- Vaccine2▲ 18×8 topics
- Public Health2▲ 5.0×6 topics
- Zoonotic Infections2▲ 111×2 topics
- Immunotherapy2▲ 8.4×5 topics
- Pandemic2▲ 12×3 topics
- Zoonotic Transmission2▲ 53×4 topics
- Diagnosis1▲ 5.1×4 topics
- Gene Therapy1▲ 19×3 topics
- Genomic Analysis1▲ 18×4 topics
- Host-Pathogen Interactions1▲ 49×2 topics
- Vector Control1▲ 43×2 topics
- Innate Immunity1▲ 14×6 topics
- Vaccines1▲ 68×2 topics
- Antibodies1▲ 51×2 topics
- Bacterial Pathogenesis1▲ 94×2 topics
- Bunyavirus1▲ 91×1 topic
- Viral Hemorrhagic Fevers1▲ 91×1 topic
- Virus1▲ 36×2 topics
- Cholera1▲ 153×1 topic
- Genomics1▲ 12×2 topics
- Regulation1▲ 6.7×2 topics
- Vibrio cholerae1▲ 153×1 topic
- H1N11▲ 107×1 topic
- Influenza1▲ 81×1 topic
Which research topics does PaxVax (United States) publish most on?
By volume in 2022–2025: Glioma Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers and Mobile Agent-Based Network Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Glioma Diagnosis and Treatment Genetics 0 works
- 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 4 Mobile Agent-Based Network Management Computer Networks and Communications 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Colorectal Cancer Treatments and Studies Oncology 0 works
- 7 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 8 Service-Oriented Architecture and Web Services Information Systems 0 works
- 9 Multi-Agent Systems and Negotiation Artificial Intelligence 0 works
- 10 Robot Manipulation and Learning Control and Systems Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PaxVax (United States)'s research output changed?
Output in 2018–2022 was 46% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Redwood City
- Heron Therapeutics (United States)
- Chan Zuckerberg Initiative (United States)
- Emergency University
- Guardant (United States)
- Box (United States)
- OncoMed (United States)
- Genomic Health (United States)
- Ubiquitous Energy (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.